Publicaciones en colaboración con investigadores/as de University of Cologne (25)

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. Comprehensive analysis of the major histocompatibility complex in systemic sclerosis identifies differential HLA associations by clinical and serological subtypes

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 8, pp. 1040-1047

  2. Genomic Risk Score impact on susceptibility to systemic sclerosis

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 1, pp. 118-127

2019

  1. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

2017

  1. Analysis of ATP8B4 F436L Missense Variant in a Large Systemic Sclerosis Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 6, pp. 1337-1338

2016

  1. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

    Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344

  2. Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway

    Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

2014

  1. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility

    Arthritis Research and Therapy, Vol. 16, Núm. 1

  2. Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus

    Arthritis and Rheumatology

2013

  1. A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci

    Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029

  2. Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes

    Clinical and Experimental Rheumatology

  3. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility

    Annals of the Rheumatic Diseases, Vol. 72, Núm. 7, pp. 1233-1238

2012

  1. A rare polymorphism in the gene for Toll-like receptor 2 is associated with systemic sclerosis phenotype and increases the production of inflammatory mediators

    Arthritis and Rheumatism, Vol. 64, Núm. 1, pp. 264-271

  2. Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis

    Arthritis Research and Therapy, Vol. 14, Núm. 3

  3. Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis

    Genes and Immunity, Vol. 13, Núm. 6, pp. 458-460

  4. Identification of CSK as a systemic sclerosis genetic risk factor through genome wide association study follow-up

    Human Molecular Genetics, Vol. 21, Núm. 12, pp. 2825-2835

  5. Influence of the IL6 gene in susceptibility to systemic sclerosis

    Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302

  6. Polymorphisms in the interleukin 4, interleukin 13, and corresponding receptor genes are not associated with systemic sclerosis and do not influence gene expression

    Journal of Rheumatology, Vol. 39, Núm. 1, pp. 112-118

2011

  1. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort

    Annals of the Rheumatic Diseases, Vol. 70, Núm. 4, pp. 638-641